Literature DB >> 8241913

Adverse reactions to influenza vaccine in elderly people: randomised double blind placebo controlled trial.

T M Govaert1, G J Dinant, K Aretz, N Masurel, M J Sprenger, J A Knottnerus.   

Abstract

OBJECTIVE: To assess the frequency and type of side effects after influenza vaccination in elderly people.
DESIGN: Randomised double blind placebo controlled study.
SETTING: 15 general practices in the southern Netherlands.
SUBJECTS: 1806 patients aged 60 or older, of whom 904 received influenza vaccine and 902 placebo. MAIN OUTCOME MEASURES: Adverse reactions reported on postal questionnaire completed four weeks after vaccination.
RESULTS: 210 (23%) patients given vaccine reported one or more adverse reactions compared with 127 (14%) given placebo. The frequency of local adverse reactions were 17.5% in the vaccine group and 7.3% in the placebo group (p < 0.001). There was no difference in systemic adverse reactions (11% v 9.4%; p = 0.34). In general, men reported fewer side effects than women.
CONCLUSION: Only local side effects were more common in vaccinated patients and all side effects were mild.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8241913      PMCID: PMC1679213          DOI: 10.1136/bmj.307.6910.988

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  16 in total

1.  A new subunit influenza vaccine: acceptability compared with standard vaccines and effect of dose on antigenicity.

Authors:  F L Ruben; G G Jackson
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

2.  The costs and benefits of preventing influenza in Ontario's elderly.

Authors:  B E Helliwell; M F Drummond
Journal:  Can J Public Health       Date:  1988 May-Jun

Review 3.  Understanding and improving patient compliance.

Authors:  S A Eraker; J P Kirscht; M H Becker
Journal:  Ann Intern Med       Date:  1984-02       Impact factor: 25.391

4.  Summary of clinical trials of inactivated influenza vaccine - 1978.

Authors:  J R La Montagne; G R Noble; G V Quinnan; G T Curlin; W C Blackwelder; J I Smith; F A Ennis; F M Bozeman
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

5.  Impact of epidemic type A influenza in a defined adult population.

Authors:  W H Barker; J P Mullooly
Journal:  Am J Epidemiol       Date:  1980-12       Impact factor: 4.897

6.  Studies of inactivated influenza virus vaccines in hospital employees: reactogenicity and absenteeism.

Authors:  S R Mostow; T C Eickhoff; G A Chelgren; H F Retailliau; M Castle
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

7.  A one-year study of trivalent influenza vaccines in primed and unprimed volunteers: immunogenicity, clinical reactions and protection.

Authors:  N Masurel; J Laufer
Journal:  J Hyg (Lond)       Date:  1984-06

8.  Pneumonia and influenza deaths during epidemics: implications for prevention.

Authors:  W H Barker; J P Mullooly
Journal:  Arch Intern Med       Date:  1982-01

9.  Study into the ability of patients with impaired lung function to use breath alcohol testing devices.

Authors:  P J Gomm; M D Osselton; C G Broster; N M Johnson; K Upton
Journal:  Med Sci Law       Date:  1991-07       Impact factor: 1.266

10.  Studies with inactivated influenza vaccines purified by zonal centrifugation. 1. Adverse reactions and serological responses.

Authors:  S R Mostow; S C Schoenbaum; W R Dowdle; M T Coleman; H S Kaye
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

View more
  56 in total

1.  The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands.

Authors:  D M Fleming; M Zambon; A I Bartelds; J C de Jong
Journal:  Eur J Epidemiol       Date:  1999-05       Impact factor: 8.082

2.  BTS Guidelines for the Management of Community Acquired Pneumonia in Adults.

Authors: 
Journal:  Thorax       Date:  2001-12       Impact factor: 9.139

3.  Prevention and treatment of influenza A and B.

Authors:  B Mintzes; K Bassett; J Wright
Journal:  Can Fam Physician       Date:  2001-11       Impact factor: 3.275

4.  Does influenza vaccination increase consultations, corticosteroid prescriptions, or exacerbations in subjects with asthma or chronic obstructive pulmonary disease?

Authors:  L J Tata; J West; T Harrison; P Farrington; C Smith; R Hubbard
Journal:  Thorax       Date:  2003-10       Impact factor: 9.139

Review 5.  Influenza and cardiovascular disease: is there a causal relationship?

Authors:  Mohammad Madjid; Ibrahim Aboshady; Imran Awan; Silvio Litovsky; S Ward Casscells
Journal:  Tex Heart Inst J       Date:  2004

6.  Influenza in The Netherlands.

Authors:  J A Knottnerus
Journal:  Pharmacoeconomics       Date:  1996       Impact factor: 4.981

Review 7.  Sex and Gender Impact Immune Responses to Vaccines Among the Elderly.

Authors:  Ashley L Fink; Sabra L Klein
Journal:  Physiology (Bethesda)       Date:  2015-11

8.  Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease.

Authors:  Zuzana Zelinkova; Evelien Bultman; Lauran Vogelaar; Cheima Bouziane; Ernst J Kuipers; C Janneke van der Woude
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  Influenza vaccination in older patients. Immunogenicity, epidemiology and available agents.

Authors:  H Glathe; W Lange
Journal:  Drugs Aging       Date:  1995-05       Impact factor: 3.923

Review 10.  Vaccines for preventing influenza in people with asthma.

Authors:  Christopher J Cates; Brian H Rowe
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.